Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancers|April 3, 2021
Charged Particle and Conventional Radiotherapy: Current Implications as Partner for ImmunotherapyDamiënne Marcus, Relinde I Y Lieverse, Carmen Klein, et al.
Molecular Oncology|May 10, 2020
Human fibronectin extra domain B as a biomarker for targeted therapy in cancerRelinde I Y Lieverse, Damiënne Marcus, Alexander M A van der Wiel, et al.
Seminars in Radiation Oncology|May 9, 2020
Lymphocyte-Sparing Radiotherapy: The Rationale for Protecting Lymphocyte-rich Organs When Combining Radiotherapy With ImmunotherapyPhilippe Lambin, Relinde I Y Lieverse, Franziska Eckert, et al.
Cancers|May 28, 2020
Hypoxia PET Imaging with [18F]-HX4-A Promising Next-Generation TracerSebastian Sanduleanu, Alexander M A van der Wiel, Relinde I Y Lieverse, et al.
International Journal of Radiation Oncology, Biology, Physics|December 7, 2020
Toxicity of L19-Interleukin 2 Combined with Stereotactic Body Radiation Therapy: A Phase 1 StudyEvert Jan Van Limbergen, Ann Hoeben, Relinde I Y Lieverse, et al.
Frontiers in Digital Health|April 8, 2024
Improving shared decision making for lung cancer treatment by developing and validating an open-source web based patient decision aid for stage I-II non-small cell lung cancerIva Halilaj, Anshu Ankolekar, Anouk Lenaers, et al.
The British Journal of Radiology|February 27, 2020
Radiomics: from qualitative to quantitative imagingWilliam Rogers, Sithin Thulasi Seetha, Turkey A G Refaee, et al.
BMC Cancer|June 17, 2020
Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trialRelinde I Y Lieverse, Evert J Van Limbergen, Cary J G Oberije, et al.
Pageof 1